FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

372740001: Centrally acting hypotensive agent (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2002. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
1198035011 Centrally acting hypotensive agent (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
1211263018 Centrally acting hypotensive agent en Synonym Active Entire term case insensitive SNOMED CT core module
3011879010 Centrally acting antihypertensive agent en Synonym Active Entire term case insensitive SNOMED CT core module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Centrally acting hypotensive agent Is a Hypotensive agent true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Syrosingopine Is a True Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Reserpine - chemical Is a False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Rescinnamine Is a True Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Substance with alpha-2 adrenergic receptor agonist mechanism of action Is a False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing alpha-2 adrenergic receptor agonist Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing deserpidine Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Dexmedetomidine hydrochloride 100mcg/mL injection solution vial Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing precisely deserpidine 250 microgram and methyclothiazide 5 milligram/1 each conventional release oral tablet Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing precisely deserpidine 500 microgram and methyclothiazide 5 milligram/1 each conventional release oral tablet Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Centrally acting hypotensive agent Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing reserpine Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Reserpine 100% Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing precisely hydralazine hydrochloride 25 milligram and hydrochlorothiazide 15 milligram and reserpine 100 microgram/1 each conventional release oral tablet Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing precisely hydrochlorothiazide 25 milligram and reserpine 125 microgram/1 each conventional release oral tablet Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing precisely hydrochlorothiazide 50 milligram and reserpine 125 microgram/1 each conventional release oral tablet Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing precisely methyclothiazide 2.5 milligram and reserpine 100 microgram/1 each conventional release oral tablet Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing chlorothiazide and reserpine Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing hydrochlorothiazide and reserpine Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing deserpidine and methyclothiazide Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing hydralazine hydrochloride and hydrochlorothiazide and reserpine Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing methyclothiazide and reserpine Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing precisely guanfacine hydrochloride 1 milligram/1 each conventional release oral tablet Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing precisely chlorothiazide 250 milligram and methyldopa 250 milligram/1 each conventional release oral tablet Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing clonidine in transdermal dose form (medicinal product form) Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Guanfacine hydrochloride 1mg extended release tablet Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Apraclonidine 1% intra-ocular solution Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Clonidine 100microgram extended release film Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Clonidine hydrochloride 100mcg/mL injection solution 10mL vial Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing clonidine in parenteral dose form (medicinal product form) Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing precisely lofexidine hydrochloride 200 microgram/1 each conventional release oral tablet Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing chlortalidone and clonidine hydrochloride Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing dexmedetomidine Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing precisely methyldopa 500 milligram/1 each conventional release oral tablet Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing precisely clonidine hydrochloride 100 microgram/1 milliliter prolonged-release oral suspension (clinical drug) Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Guanfacine hydrochloride 4mg extended release tablet Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Clonidine 7.5mg/unt Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Clonidine 2.5mg/unt Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing guanabenz Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing precisely hydrochlorothiazide 25 milligram and methyldopa 250 milligram/1 each conventional release oral tablet Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Clonidine 200microgram extended release film Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Clonidine hydrochloride 150micrograms/mL injection solution 1mL ampule Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing precisely guanfacine hydrochloride 2 milligram/1 each conventional release oral tablet Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing precisely apraclonidine (as apraclonidine hydrochloride) 5 milligram/1 milliliter conventional release eye drops Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing precisely hydrochlorothiazide 50 milligram and methyldopa 500 milligram/1 each conventional release oral tablet Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing apraclonidine Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing precisely methyldopa 250 milligram/1 each conventional release oral capsule Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing guanfacine Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing precisely hydrochlorothiazide 30 milligram and methyldopa 500 milligram/1 each conventional release oral tablet Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing clonidine in oral dose form (medicinal product form) Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Guanfacine hydrochloride 3mg extended release tablet Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing precisely hydrochlorothiazide 15 milligram and methyldopa 250 milligram/1 each conventional release oral tablet Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Clonidine 5mg patch Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Clonidine 0.1mg patch Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing precisely chlortalidone 15 milligram and clonidine hydrochloride 200 microgram/1 each conventional release oral tablet Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Clonidine hydrochloride 0.5mg/mL injection solution 10mL vial Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing precisely clonidine hydrochloride 100 microgram/1 each conventional release oral tablet Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing precisely guanabenz acetate 8 milligram/1 each conventional release oral tablet Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Guanfacine hydrochloride 2mg extended release tablet Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing clonidine Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing precisely clonidine hydrochloride 300 microgram/1 each conventional release oral tablet Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing precisely methyldopa 125 milligram/1 each conventional release oral tablet Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing precisely chlortalidone 15 milligram and clonidine hydrochloride 300 microgram/1 each conventional release oral tablet Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing precisely guanabenz acetate 4 milligram/1 each conventional release oral tablet Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing guanfacine hydrochloride Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing precisely methyldopa 250 milligram/1 each conventional release oral tablet Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing hydrochlorothiazide and methyldopa Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing methyldopa Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Clonidine 300microgram extended release film Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing lofexidine Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Clonidine 4mg/patch Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing chlorothiazide and methyldopa Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Clonidine hydrochloride 250micrograms m/r capsule Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing precisely clonidine hydrochloride 200 microgram/1 each conventional release oral tablet Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing precisely clonidine hydrochloride 25 microgram/1 each conventional release oral tablet Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing methyldopa in oral dose form (medicinal product form) Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Product containing central alpha-adrenoceptor agonist Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Guanfacine 1mg modified-release tablets Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Guanfacine 2mg modified-release tablets Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Guanfacine 3mg modified-release tablets Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Guanfacine 4mg modified-release tablets Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Intuniv 1mg modified-release tablets (Takeda UK Ltd) Has active ingredient True Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Intuniv 2mg modified-release tablets (Takeda UK Ltd) Has active ingredient True Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Intuniv 3mg modified-release tablets (Takeda UK Ltd) Has active ingredient True Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Intuniv 4mg modified-release tablets (Takeda UK Ltd) Has active ingredient True Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Clonidine 250micrograms/5ml oral solution Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Clonidine 250micrograms/5ml oral suspension Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Clonidine 250micrograms/5ml oral solution (Special Order) Has active ingredient True Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Clonidine 250micrograms/5ml oral suspension (Special Order) Has active ingredient True Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Clonidine 25microgram tablets (Kent Pharma (UK) Ltd) Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Guanfacine 1mg tablets (Special Order) Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Clonidine 62.5micrograms/5ml oral suspension Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Clonidine 62.5micrograms/5ml oral suspension (Special Order) Has active ingredient True Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Clonidine 3.75micrograms/5ml oral suspension Has active ingredient False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier
Clonidine 3.75micrograms/5ml oral suspension (Special Order) Has active ingredient True Centrally acting hypotensive agent Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start